ANDA 74245, held by West-Ward Pharms Int. Cytarabine.
As of Nov 16, 2026, ANDA 74245 (Cytarabine), held by West-Ward Pharms Int, was first approved by FDA on Aug 31, 1994, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 31, 1994 | Original application | Approved | None posted |
| Cytarabine1GM/VIAL · injectable;injection | Cytarabine | Rx |
| Cytarabine2GM/VIAL · injectable;injection | Cytarabine | Rx |
| Mar 27, 2001 | Supplement 3Manufacturing | Approved | None posted |
| Oct 13, 2000 | Supplement 4Labeling | Approved | None posted |
| Mar 23, 1999 | Supplement 2Manufacturing | Approved | None posted |
| Jul 11, 1997 | Supplement 1Labeling | Approved | None posted |
| Aug 31, 1994 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters